Lincoln Pharmaceuticals Limited

NSE:LINCOLN.NS

659.3 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 933.0491,004.798959.394837.205672.324621.945462.471368.43236.823150.121106.54396.62351.18841.66461.04370.682
Depreciation & Amortization 106.24791.66180.87875.60373.26266.7961.11855.36448.65845.68135.4926.48419.32816.66811.6058.627
Deferred Income Tax 0000000000000000
Stock Based Compensation 0000000000000000
Change In Working Capital -161.165-313.73524.0852.043143.31-11.177-254.875-178.19948.044-18.048-175.594-231.461-63.774-317.417-179.783-48.104
Accounts Receivables -260.856-202.119-31.192-100.827190.163-137.053-209.07946.127370.4620000000
Inventory -71.40227.141-261.2927.835-111.70391.857-81.054-98.241-56.6350026.47447.988000
Accounts Payables 215.728-205.142145.92955.49672.28-1.404110.202-73.44200000000
Other Working Capital -44.63566.385170.6439.539-7.4335.423-173.821-79.958-265.783-25.048-175.594-257.935-111.763000
Other Non Cash Items 160.276-390.105-303.037-222.153-134.744-149.113-37.235-39.362114.46267.83679.946234.56111.93353.1921.681-15.925
Operating Cash Flow 709.383392.619761.32692.698754.152528.446231.479206.233447.987245.5946.384126.206118.675-205.893-105.45415.28
Investing Activities:
Investments In Property Plant And Equipment -396.13-142.82-455.251-87.503-76.908-149.378-99.011-176.02-337.297-39.355-39.165-187.835-170.984-127.718-61.6-65.744
Acquisitions Net 0.9-179.548-92.6990.520.169.3162.2690.17-71.6771.899000000
Purchases Of Investments -1,063.81-631.869-530.473-545.027-319.84-313.7510-101.981-73.403-14.249000000
Sales Maturities Of Investments 1,031.28738.011405.177105.04270.107212.9262.04800116.92142.4360000.01529.361
Other Investing Activites -235.607-150.202-107.556-115.283-2.34559.01216.136-53.57-7.173011.24814.151-101.32418.781.3710.281
Investing Cash Flow -663.367-366.428-780.802-642.271-308.826-181.875-82.874-229.59-417.87365.21614.519-173.684-272.308-108.938-60.214-36.102
Financing Activities:
Debt Repayment -9.019-195.018-5.197-45.543-293.446-276.776-66.969-65.756-15.616-252.324-24.342-362.8470000
Common Stock Issued 0000000226.88675.6290000502710
Common Stock Repurchased 0000000000000000
Dividends Paid -30.045-30.045-300-72.334-36.167-28.747-19.571-19.724-11.45-11.45-11.45-11.374-15.88-13.573-9.132
Other Financing Activities -21.759180.0519.636-11.913-11.809-44.739-18.366104.567-14.46-56.634-69.32831.974173.229258.663241.12332.795
Financing Cash Flow -39.064-45.012-25.561-57.456-377.589-357.682-114.08219.239-34.184-320.408-105.1220.524161.855292.783254.5533.663
Other Information:
Effect Of Forex Changes On Cash 00.0010-0.8930.00100-00-000-0000
Net Change In Cash 86.094-18.821-45.043-7.02967.738-11.11134.523-4.118-4.069-9.602-44.216-26.9538.222-22.04888.88212.841
Cash At End Of Period 138.30650.5269.34114.384122.30654.56865.67930.18133.38640.10149.70396.616123.569112.827134.87545.993